Late-life psychosis: diagnosis and treatment
- PMID: 25617038
- DOI: 10.1007/s11920-014-0542-0
Late-life psychosis: diagnosis and treatment
Abstract
Psychosis is one of the most common conditions in later life with a lifetime risk of 23 %. Despite its high prevalence, late-onset psychosis remains a diagnostic and treatment dilemma. There are no reliable pathognomonic signs to distinguish primary or secondary psychosis. Primary psychosis is a diagnosis of exclusion and the clinician must rule out secondary causes. Approximately 60 % of older patients with newly incident psychosis have a secondary psychosis. In this article, we review current, evidence-based diagnostic and treatment approaches for this heterogeneous condition, emphasizing a thorough evaluation for the "six d's" of late-life psychosis (delirium, disease, drugs dementia, depression, delusions). Treatment is geared towards the specific cause of psychosis and tailored based on comorbid conditions. Frequently, environmental and psychosocial interventions are first-line treatments with the judicious use of pharmacotherapy as needed. There is an enormous gap between the prevalence of psychotic disorders in older adults and the availability of evidence-based treatment. The dramatic growth in the elderly population over the first half of this century creates a compelling need to address this gap.
Similar articles
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
-
Correlates of psychotic symptoms among elderly outpatients.Int J Geriatr Psychiatry. 1999 May;14(5):379-84. Int J Geriatr Psychiatry. 1999. PMID: 10389042
-
The treatment of psychosis in late life.J Clin Psychiatry. 1998;59 Suppl 1:5-10; discussion 11-2. J Clin Psychiatry. 1998. PMID: 9448664 Review.
-
Psychotic and Bipolar Disorders: Behavioral Disorders in Dementia.FP Essent. 2017 Apr;455:18-22. FP Essent. 2017. PMID: 28437057 Review.
-
Recent advances in pharmacological treatment of psychosis in late life.Curr Opin Psychiatry. 2011 Nov;24(6):455-60. doi: 10.1097/YCO.0b013e32834a3f47. Curr Opin Psychiatry. 2011. PMID: 21799414
Cited by
-
Diagnostic Transitions from Primary Psychiatric Disorders to Underlying Medical Conditions: A 5-Year Retrospective Survey from a University Hospital Sample.Alpha Psychiatry. 2024 Mar 1;25(2):226-232. doi: 10.5152/alphapsychiatry.2024.231274. eCollection 2024 Mar. Alpha Psychiatry. 2024. PMID: 38798811 Free PMC article.
-
Ectopic parathyroid adenoma causing hyperparathyroidism-induced psychosis: A case report.SAGE Open Med Case Rep. 2023 Jul 6;11:2050313X231180752. doi: 10.1177/2050313X231180752. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37434899 Free PMC article.
-
Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review.J Geriatr Psychiatry Neurol. 2023 Nov;36(6):435-460. doi: 10.1177/08919887231164357. Epub 2023 Mar 20. J Geriatr Psychiatry Neurol. 2023. PMID: 36941085 Free PMC article. Review.
-
Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States.BMC Geriatr. 2022 Oct 6;22(1):784. doi: 10.1186/s12877-022-03489-3. BMC Geriatr. 2022. PMID: 36203129 Free PMC article.
-
Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients.Int J Mol Sci. 2022 Aug 24;23(17):9591. doi: 10.3390/ijms23179591. Int J Mol Sci. 2022. PMID: 36076984 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
